| 000 | 01825 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515080901.0 | ||
| 264 | 0 | _c20080102 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a0021-972X | ||
| 024 | 7 |
_a10.1210/jc.2007-0597 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDardano, A | |
| 245 | 0 | 0 |
_aAnticlastogenic effect of Ginkgo biloba extract in Graves' disease patients receiving radioiodine therapy. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cNov 2007 |
||
| 300 |
_a4286-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntimutagenic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aChromosome Breakage _xdrug effects |
| 650 | 0 | 4 | _aDietary Supplements |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGinkgo biloba _xchemistry |
| 650 | 0 | 4 |
_aGraves Disease _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIodine Radioisotopes _xtherapeutic use |
| 650 | 0 | 4 |
_aLymphocytes _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicronucleus Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlant Extracts _xadministration & dosage |
| 650 | 0 | 4 |
_aThyrotropin _xblood |
| 650 | 0 | 4 |
_aThyroxine _xblood |
| 650 | 0 | 4 |
_aTriiodothyronine _xblood |
| 700 | 1 | _aBallardin, M | |
| 700 | 1 | _aFerdeghini, M | |
| 700 | 1 | _aLazzeri, E | |
| 700 | 1 | _aTraino, C | |
| 700 | 1 | _aCaraccio, N | |
| 700 | 1 | _aMariani, G | |
| 700 | 1 | _aBarale, R | |
| 700 | 1 | _aMonzani, F | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 92 _gno. 11 _gp. 4286-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2007-0597 _zAvailable from publisher's website |
| 999 |
_c17242682 _d17242682 |
||